Chembio Diagnostics to Report Second Quarter 2022 Financial Results on August 4, 2022
HAUPPAUGE, N.Y., July 21, 2022 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the second quarter of more...
Corvus Pharmaceuticals Appoints Dr. James Rosenbaum Senior Vice President of Research
BURLINGAME, Calif., July 21, 2022 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced the appointment of James Rosenbaum, M.D. as Senior Vice President of Research, more...
Champions Oncology Reports Quarterly Revenue of $12.9 Million
Record Annual Revenue of $49.1 Million HACKENSACK, NJ / ACCESSWIRE / July 21, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today more...
Thomas Von Koch Acquires Common Shares of DiaMedica Therapeutics Inc.
Toronto, Ontario–(Newsfile Corp. – July 21, 2022) – Thomas Von Koch (the “Acquiror“), c/o EQT Partners AB, Box 16509, 103 27 Stockholm, Sweden, acquired indirect ownership, through TomEnterprise AB, of an aggregate of 304,827 common more...
The Power Play by The Market Herald Releases New Interviews with Argentina Lithium, Tocvan Ventures, Datametrex, SoLVBL, and Eloro Resources
VANCOUVER, BC / ACCESSWIRE / July 21, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Argentina Lithium, Tocvan Ventures, Datametrex, SoLVBL, and Eloro Resources on their more...
5 Cheap Healthcare Stocks in 2022
(0:45) – Are There Value Stocks In The Healthcare Sector? (6:00) – Tracey’s Top Stock Picks (19:50) – Episode Roundup: MRK, MRVI, SRTS, PETQ, ABBV [email protected] Welcome to Episode #290 of the Value Investor Podcast. more...
Lantheus (LNTH) to Report Q2 Results: What’s in the Cards?
Lantheus Holdings, Inc. LNTH is expected to report second-quarter 2022 results on Jul 27. In the last reported quarter, the company’s earnings of 97 cents per share surpassed the Zacks Consensus Estimate by 110.9%. Its more...
Zelira’s Zenivol(TM), the World’s First Clinically Validated Cannabinoid Medication for Insomnia, Achieves Regulatory Approval in Germany
Zelira’s Zenivol™, the World’s First Clinically Validated Cannabinoid Medication for Insomnia, Achieves Regulatory Approval in Germany PR Newswire PHILADELPHIA , July 21, 2022 /PRNewswire/ — Zelira Therapeutics Ltd (ASX: ZLD, OTC-QB: ZLDAF), a global leader more...
Verve (VERV) Up on Gene Editing Collaboration With Vertex
Shares of Verve Therapeutics VERV increased11.21% on Jul 20 after the company announced a collaboration with biotech giant Vertex Pharmaceuticals VRTX to develop a gene editing program for a liver disease. Per the terms of more...
Quest Diagnostics (DGX) Tops Q2 Earnings Estimates, Ups View
Quest Diagnostics Incorporated ‘s DGX second-quarter 2022 adjusted earnings per share of $2.36 beat the Zacks Consensus Estimate by 9.8%. Adjusted earnings, however, plunged 25.8% from the year-ago adjusted figure. Certain one-time expenses, like the more...